Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)

Publication date: June 2016 Source:Biomolecular Detection and Quantification, Volume 8 Author(s): Ian A. Cree RAS mutation analysis is an important companion diagnostic test. Treatment of colorectal cancer with anti-Epidermal Growth Factor Receptor (EGFR) therapy requires demonstration of RAS mutation status (both KRAS and NRAS), and it is good practice to include BRAF. In Non-Small Cell Lung Cancer (NSCLC) and melanoma, assessment of RAS mutation status can be helpful in triaging patient samples for more extensive testing. This mini-review will discuss the role of PCR methods in providing rapid diagnostic information for cancer patients.
Source: Biomolecular Detection and Quantification - Category: Molecular Biology Source Type: research